Hepasil Syrup, containing Silymarin 35 mg per dose, is a hepatoprotective agent widely used to support liver function and promote hepatic cell regeneration. Silymarin, a flavonoid complex extracted from the seeds of Silybum marianum (milk thistle), exhibits potent antioxidant, anti-inflammatory, and antifibrotic properties, which contribute to its therapeutic efficacy in various liver disorders. Hepasil Syrup is indicated for the management of acute and chronic liver diseases, including hepatitis, cirrhosis, and fatty liver disease, as well as for the prevention of liver damage caused by toxins, alcohol, and certain medications. By stabilizing hepatocyte membranes and enhancing protein synthesis, Silymarin facilitates the repair of damaged liver tissue and improves overall liver function. The syrup formulation allows for ease of administration, particularly in pediatric and geriatric populations who may have difficulty swallowing tablets. Hepasil Syrup should be used under medical supervision, with dosage adjusted according to the severity of the condition and patient response. Common side effects are rare but may include mild gastrointestinal disturbances. It is contraindicated in patients with known hypersensitivity to milk thistle or any component of the formulation. Regular monitoring of liver function tests is recommended during prolonged therapy to assess treatment efficacy and safety.